Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-02

Clinical Trial Update: Efficacy and Safety of the Combination of Ketoprofen and Cyclobenzaprine and Caffeine in Osteomuscular Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial update on the combination of ketoprofen, cyclobenzaprine, and caffeine for musculoskeletal pain; results completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caffeine (caffeine)
  • Cyclobenzaprine (cyclobenzaprine)
  • Ketoprofen (Ketoprofen)

Snippet

Sponsor: EMS | Conditions: Musculoskeletal Pain | Phase 3 | Status: COMPLETED